Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration

Thrombosis Research

Volumn 128, Issue 2, 2011, Pages 179-185

  Zhao, Bilian ^a   Luo, Xinping ^a   Shi, Haiming ^a   Ma, Duan ^b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

atherosclerosis; migration; proliferation; tissue factor pathway inhibitor 2 (TFPI 2); vascular smooth muscle cells (VSMCs)

Indexed keywords

CYCLIN D1; FOCAL ADHESION KINASE; GELATINASE A; GELATINASE B; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; PLACENTA PROTEIN 5;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSDUCTION; GLYCOSYLATION; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; VASCULAR SMOOTH MUSCLE;

APOPTOSIS; CELL GROWTH PROCESSES; CELL MOVEMENT; CELLS, CULTURED; CYCLIN D1; DOWN-REGULATION; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GLYCOPROTEINS; HUMANS; LIPOPROTEINS, LDL; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; RNA, MESSENGER; TRANSDUCTION, GENETIC;

EID: 79960391880     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.02.025     Document Type: Article

References (24)

1. A.C. Newby, and A.B. Zaltsman Molecular mechanisms in intimal hyperplasia J Pathol 190 2000 300 309 (Pubitemid 30141376)
2. J. Hu, P.E. Van den Steen, Q.X. Sang, and G. Opdenakker Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases Nat Rev Drug Discov 6 2007 480 498 (Pubitemid 47064570)
3. M. Iino, D.C. Foster, and W. Kisiel Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2 Arterioscler Thromb Vasc Biol 18 1998 40 46 (Pubitemid 28047597)
4. K. Udagawa, Y. Miyagi, F. Hirahara, E. Miyagi, Y. Nagashima, and H. Minaguchi Specific expression of PP5/TFPI2 mRNA by syncytiotrophoblasts in human placenta as revealed by in situ hybridization Placenta 19 1998 217 223 (Pubitemid 28112206)
5. Y. Liu, S.M. Stack, S.S. Lakka, A.J. Khan, D.T. Woodley, J.S. Rao, and C.N. Rao Matrix localization of tissue factor pathway inhibitor-2/matrix- associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin Arch Biochem Biophys 370 1999 112 118 (Pubitemid 29476957)
6. C.N. Rao, P. Reddy, Y. Liu, E. O'Toole, D. Reeder, and D.C. Foster Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2 Arch Biochem Biophys 335 1996 82 92 (Pubitemid 26382681)
7. L.C. Petersen, C.A. Sprecher, D.C. Foster, H. Blumberg, T. Hamamoto, and W. Kisiel Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor Biochemistry 35 1996 266 272 (Pubitemid 26036431)
8. C.N. Rao, B. Cook, Y. Liu, K. Chilukuri, M.S. Stack, and D.C. Foster HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI Int J Cancer 76 1998 749 756 (Pubitemid 28243950)
9. M.P. Herman, G.K. Sukhova, W. Kisiel, D. Foster, M.R. Kehry, and P. Libby Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis J Clin Invest 107 2001 1117 1126 (Pubitemid 32422908)
10. H. Izumi, C. Takahashi, J. Oh, and M. Noda Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes FEBS Lett 481 2000 31 36 (Pubitemid 30662372)
11. Z. Xu, D. Maiti, W. Kisiel, and E.J. Duh Tissue factor pathway inhibitor-2 is upregulated by vascularendothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells Arterioscler Thromb Vasc Biol 26 2006 2819 2825
12. T. Higashikata, M. Yamagishi, T. Higashi, I. Nagata, K. Iihara, and S. Miyamoto Altered expression balance of matrix metalloproteinases and their inhibitors in human carotid plaque disruption: results of quantitative tissue analysis using real-time RT-PCR method Atherosclerosis 185 1 2006 Mar 165 172 (Pubitemid 43117564)
13. C. Zawadzki, N. Chatelain, M. Delestre, S. Susen, B. Quesnel, and F. Juthier Tissue factor pathway inhibitor-2 gene methylation is associated with low expression in carotid atherosclerotic plaques Atherosclerosis 204 2 Jun 2009 e4 e14
14. Y. Ishigaki, Y. Oka, and H. Katagiri Circulating oxidized LDL: a biomarker and a pathogenic factor Curr Opin Lipidol 20 5 Oct 2009 363 369 Review
15. Absence of Akt1 reduces vascular smooth muscle cell migration and survival and induces features of plaque vulnerability and cardiac dysfunction during atherosclerosis Arterioscler Thromb Vasc Biol 29 2009 2033 2040
16. T. Yoshida, and G.K. Owens Molecular determinants of vascular smooth muscle cell diversity Circ Res 96 2005 280 291 (Pubitemid 40279902)
17. H. Hanke, T. Strohschneider, M. Oberhoff, E. Betz, and K.R. Karsch Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty Circ Res 67 3 Sep 1990 651 659 (Pubitemid 20314992)
18. V. Andres Control of vascular smooth muscle cell growth and its implication in atherosclerosis and restenosis (review) Int J Mol Med 2 1 Jul 1998 81 89 Review
19. J. Ekstrand, A. Razuvaev, L. Folkersen, J. Roy, and U. Hedin Tissue factor pathway inhibitor-2 is induced by fluid shear stress in vascular smooth muscle cells and affects cell proliferation and survival J Vasc Surg 52 1 Jul 2010 167 175
20. N. Augé, F. Maupas-Schwalm, M. Elbaz, J.C. Thiers, A. Waysbort, and S. Itohara Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation Circulation 110 5 Aug 3 2004 571 578 (Pubitemid 39031175)
21. E. Shinoda, Y. Yui, R. Hattori, M. Tanaka, R. Inoue, and T. Aoyama Tissue factor pathway inhibitor-2 is a novel mitogen for vascular smooth muscle cells J Biol Chem 274 9 Feb 26 1999 5379 5384 (Pubitemid 29109181)
22. Y. Ishigaki, Y. Oka, H. Katagiri, R. Monticone, L. Cheng, and N. Papadopoulos Circulating oxidized LDL: a biomarker and a pathogenic factor Curr Opin Lipidol 20 5 Oct 2009 363 369 Review
23. R. Pauly, A. Passaniti, and C. Bilato Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation Circ Res 75 1 Jul 1994 41 54 (Pubitemid 24187734)
24. Brewster L, Ucuzian A, Brey E, et al. FRNK Overexpression Limits the Depth and Frequency of Vascular Smooth Muscle Cell Invasion in a Three-Dimensional Fibrin Matrix. J Cell Physiol. 2010 May 20. [Epub ahead of print].